1 completed, 1 unknown, 1 withdrawn. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Perhexiline: new trials by email Literature Review of Perhexiline trials Research Report on Perhexiline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy Perhexiline, Placebo marked PEXSIG - Myocardial Reperfusion Injury, Cardiac Output, Low | Phase 2 / Phase 3 | Unknown | University Hospital Birmingham | 220 | 2009-10-01 | 2011-08-11 |
| Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery Perhexiline, Placebo marked PEXSIG - Myocardial Reperfusion Injury, Cardiac Output, Low | Phase 2 / Phase 3 | Completed | University Hospital Birmingham | 290 | 2007-02-01 | 2010-05-20 |
| Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure Perhexiline, Placebo - Hypertrophic Cardiomyopathy | Phase 3 | Withdrawn | Heart Metabolics Limited | 2017-07-14 |
Cardiac Output, Low (2) · Myocardial Reperfusion Injury (2) · Aortic Valve Stenosis (1) · Cardiomyopathy, Hypertrophic (1) · Hypertrophy, Left Ventricular (1)
University Hospital Birmingham (2) · Heart Metabolics Limited (1)
United Kingdom (2)